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Background. There is very limited data available on the association between underage drinking and risk of diabetes. The aim of
this study is to investigate the association between alcohol use during adolescence and the risk of diabetes while controlling for
a wide range of confounders, including parental alcohol use. Methods. This population-based study used data collected from the
National Longitudinal Study of Adolescent Health (Add Health). Participants were initially recruited in 1994-1995 (Wave I), then
followed up in 1996 (Wave II) and in 2001-2002 (Wave III), and in 2008-2009 (Wave IV). Analysis included 2,850 participants (46%
male) who were successfully followed up at Waves I, III, and IV without a known diagnosis of diabetes at Waves I and III and who
provided all necessary information for the analysis. Results. During adolescence, frequent alcohol consumption at levels reaching 5
or more drinks, 3–7 days/week, substantially increased the risk of diabetes in young adulthood, with an odds ratio of 12.57 (95% CI
4.10–38.61) compared to current abstainers. Conclusions. Heavy alcohol use during adolescence may increase the risk of diabetes
in young adulthood.The Significant finding of the Study.
1. Introduction
Diabetes mellitus has become a major global public health
problem [1, 2]. It has been estimated that diabetes currently
affects 347 million people worldwide [2]. As a chronic
condition, diabetes can lead to serious complications such as
cardiovascular disease, nephropathy, and infection which are
major direct causes of morbidity and mortality [1]. Type 2
diabetes accounts for more than 90% of diabetes cases [2].
Overweight, obesity, and being physically inactive are major
risk factors for type 2 diabetes; however, prevention can be
achieved by lifestyle modification such as eating a balanced
diet and taking regular physical activity [3, 4].
Alcohol use, a common social behavior in most parts of
theworld, has been investigated for its possible role in relation
to the onset of diabetes in a number of observational studies
[5, 6]. A relatively recent meta-analysis of cohort studies
which have investigated the association between alcohol
consumption and diabetes risk showed that, compared to
lifetime abstainers, moderate drinkers had a reduced risk
of diabetes [7]. However, this observed protective effect has
been demonstrated to be moderated, at least in part, by the
residual confounding effects of socioeconomic, behavioural,
psychological, and genetic factors [7–10]. Nearly all published
studies only included participants who were at least 30 years
of age at baseline [7]. As childhood obesity and underage
drinking have become increasingly common over the last few
decades [11, 12], it is important to investigate whether alcohol
use among adolescents may affect the risk of diabetes. The
aim of this study is to investigate the association between
alcohol use during adolescence and the risk of diabetes
while controlling for a wide range of confounders, including
parental alcohol use.
2. Method
This study used data collected from theNational Longitudinal
Study of Adolescent Health (Add Health). Details of the Add
Health study have been described previously [13] and can be
accessed at the AddHealth website: http://www.cpc.unc.edu/
projects/addhealth. Briefly, Add Health is a longitudinal
study with a representative sample of adolescents in grades
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7–12 (grades equivalent to the Australian education system)
at baseline. Participants were initially recruited in 1994-
1995 (Wave I, mean age 15.75) and then followed up in
1996 (Wave II, mean age 16), in 2001- 2002 (Wave III,
mean age 22.16), and in 2007-2008 (Wave IV, mean age
28.67). A combination of self-administered questionnaires
and interviews was employed to collect social, psycholog-
ical, and health information, including demographics, risk
behaviors, health status, and family composition. In addition,
the Wave I survey also included a face-to-face interview
with one parent (preferably the mother) of each participant
to provide further information on the adolescent and other
family members, including health problems and lifestyles.
In addition to interview, the Wave IV survey collected
biologicalmeasures of glucose homeostasis including glucose
and hemoglobin A1c (HbA1c, %) [14]. The current study
used public-use data collected from Wave I, Wave III, and
Wave IV of the Add Health study. Only participants who
were successfully followed up in Waves III and IV and who
provided information for all variables required in the analysis
were included in the study (i.e., there were nomissing values).
Alcohol consumption during adolescence and young
adulthoodwas determined based on the survey data collected
in Waves I and III. In Wave I, participants were asked, “Have
you had a drink of beer, wine, or liquor—not just a sip or a
taste of someone else’s drink—more than 2 or 3 times in your
life.” In Wave III, participants were asked the same question
about their drinking since Wave I (June, 1995). If, in either
wave, the answer was yes, the participant was then asked,
“During the past 12 months, on howmany days did you drink
alcohol?” If the answer was more than one or two day(s),
they were further asked about how many drinks they usually
consumed each time they drank; that is, “Think of all the
times you have had a drink during the past 12 months. How
many drinks did you usually have each time? (A “drink” is
a glass of wine, a can of beer, a wine cooler, a shot glass
of liquor, or a mixed drink.)” Based on answers to these
questions, we coded participants according to the frequency
and quantity of their alcohol use. Frequency was recoded into
five levels based on the original eight categories applied in the
survey: (i) lifetime abstainers who never had 2 drinks ormore
over their lifetime, (ii) those who had 2 drinks or more over
their lifetime but not in the last 12 months, (iii) those who
drank 1–12 days/year, (iv) those who drank 2–8 days/month,
and (v) those who drank 3–7 days/week. Quantity of alcohol
use per occasion was measured by number of drinks in the
original questionnaire. The Centers for Disease Control and
Prevention defined heavy alcohol use or binge drinking as 5
drinks ormore per occasion (http://www.cdc.gov).Therefore,
in this study, the average quantity of alcohol drunk per
occasion was defined as follows: (i) none; (ii) 1–4 drinks; and
(iii) 5+ drinks. The same definitions were used for alcohol
consumption at Waves I and III.
Diabetic status was determined in Wave IV; participants
who reported having diabetes at Wave I and/or Wave III
were excluded from the analysis. This study used the same
definition of diabetes as the Add Health study: a participant
was considered to have diabetes if they had a fasting glucose
≥126mg/dL (7mmol/L), or nonfasting glucose ≥200mg/dL
(11mmol/L), or HbA1c ≥6.5%, or self-reported history of
diabetes (except during pregnancy) or used antidiabetic
medication in the past four weeks [14].
2.1. Data Analysis. We created a variable each for Wave
I and Wave III which represented the matrix of drinking
frequency by quantity among participants at each survey
wave: (i) 1–12 days/year, 5+ drinks/occasion; (ii) 1–12
days/year, <5 drinks/occasion; (iii) 2–8 days/month, 5+
drinks/occasion; (iv) 2–8 days/month, <5 drinks/occasion;
(v) 3–7 days/week, <5 drinks/occasion; and (vi) 3–7
days/week, 5+ drinks/occasion.
Multivariate logistic regressionwas used to investigate the
association between alcohol use during adolescence and risk
of diabetes in young adulthood. Information on a number of
potential confounding factors was obtained from the surveys
and controlled for in multivariate analyses, including gender,
age at Wave IV, race, BMI (calculated from measured weight
and height) atWave III, parental self-reported diabetic status,
frequency of parental alcohol use (from Wave I), smoking
status at Waves I and III, urbanity, and median income of
residential location at Wave I (variables controlled for are
shown in Table A1; see Supplementary Material available
online at http://dx.doi.org/10.1155/2014/795741). In order to
further control for residual confounding effects, a proxy
outcome (parental self-reported diabetic status) was used to
estimate the effects of residual confounding effects. Similar
approach has been used to examine the “protective” effect
of moderate alcohol use [8, 15]. This was achieved by using
parental self-reported diabetic status as the outcome variable
instead of diabetic status of the index participant, while
keeping all the controlled variables unchanged but excluding
parental self-reported diabetic status from the controlled
variable list.This approach assumes that alcohol use by partic-
ipants has no physiological effects on their parental diabetic
status, while a person’s diabetes status and his/her parental
diabetic status share a similar set of confounding factors.
Any association between parental diabetic status and alcohol
use was in fact manipulated by residual confounding effects.
If significant residual confounding effects were observed,
then the observed residual effects will be offset in the final
model. STATA Statistical Software: Release 11 developed by
StataCorp LP was used to perform all analyses. Sampling
weight provided by the AddHealth studywas assigned as “the
sampling weight” in multivariate logistic regression as indi-
cated in the guideline for analysis of theAddHealthData [16].
3. Results
Analyses included 2,850 participants who were successfully
followed up atWaves I, III, and IVwithout a known diagnosis
of diabetes at Waves I and III and who provided valid infor-
mation on all measures (i.e., including alcohol consumption
and potential confounders). This constituted 67% of the
participants who were successfully followed up at Waves I,
III, and IV. The mean (median) age at Waves I, III, and IV
was 15.75 (15.79), 22.16 (22.15), and 28.67 (28.66), respectively.
6.0% of these participants had developed diabetes byWave IV
(Table 1). No significant risk difference was observed between
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Table 1: Description of participants.




Age strata by quartiles (Wave III)
1st strata 35 739
2nd strata 41 759
3rd strata 42 679





Wave I alcohol consumption
Lifetime abstainer 96 1,368
Current abstainer 9 231
3–7 days/week, <5 drinks/occasion 2 26
3–7 days/week, 5+ drinks/occasion 13 57
2–8 days/month, <5 drinks/occasion 7 175
2–8 days/month, 5+ drinks/occasion 6 220
1–12 days/year, <5 drinks/occasion 33 572
1–12 days/year, 5+ drinks/occasion 6 201
Wave III alcohol consumption
Lifetime abstainer 54 588
Current abstainer 9 121
3–7 days/week, <5 drinks/occasion 5 112
3–7 days/week, 5+ drinks/occasion 12 157
2–8 days/month, <5 drinks/occasion 28 605
2–8 days/month, 5+ drinks/occasion 21 449
1–12 days/year, <5 drinks/occasion 36 629






males and females. When compared to white Americans,
African Americans had significantly higher risk of diabetes
(Table A1).
In the first multivariate analysis, adolescents who
reported never having had any alcohol (lifetime abstainers)
were used as the reference group (Table A1). The analyses
were then repeated using adolescents who reported ever
consuming alcohol but none in the past 12 months as the
reference group, that is, current abstainers (Table 2). As
shown in Table A1, at Wave I, both (i) current drinkers
who consumed alcohol 2–8 days/month and 5+ drinks on
average per occasion (OR = 0.20, incidence rate = 4.55 per
1,000 person-years) and (ii) current abstainers (OR = 0.34,
incidence rate = 6.49 per 1,000 person-years) had lower
risks of diabetes compared to lifetime abstainers (incidence
rate = 11.69 per 1,000 person-years). However, adolescents
who consumed alcohol 3–7 days/week and an average of 5+
drinks per occasion had a significantly higher risk of diabetes
compared to lifetime abstainers (OR = 4.24, incidence rate =
38.01 per 1,000 person-years). No significant association was
observed between alcohol consumption and risk of diabetes
atWave III when lifetime abstainers were the reference group
(Table A1).
It was also apparent that adolescents at Wave I whose
fathers had not consumed alcohol in the last 12 months
had significantly higher risk of having developed diabetes
by Wave IV compared to those whose fathers consumed
alcohol once or less per month (OR = 2.29). Adolescents
whosemothers consumed alcohol 2 to 3 times permonth had
significantly lower risk of diabetes compared to those whose
mothers consumed alcohol once or less frequently per month
(OR = 0.34) (Table A1).
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Table 2: Alcohol consumption during adolescence and risk of diabetes, controlling for multiple confounders and using current abstainers as
reference group∗.
Odds ratio 95% CI
Alcohol consumption at Wave I
Lifetime abstainer∧ 2.97 1.30 6.79
Current abstainer reference
3–7 days/week, <5 drinks/occasion 0.98 0.14 6.97
3–7 days/week, 5+ drinks/occasion∧ 12.57 4.10 38.61
2–8 days/month, <5 drinks/occasion 1.39 0.42 4.62
2–8 days/month, 5+ drinks/occasion 0.58 0.16 2.12
1–12 days/year, <5 drinks/occasion∧ 2.46 1.04 5.82
1–12 days/year, 5+ drinks/occasion 1.16 0.35 3.77
Alcohol consumption at Wave III
Lifetime abstainer 1.56 0.59 4.16
Current abstainer reference
3–7 days/week, <5 drinks/occasion 1.03 0.24 4.53
3–7 days/week, 5+ drinks/occasion 1.18 0.35 3.91
2–8 days/month, <5 drinks/occasion 0.88 0.30 2.55
2–8 days/month, 5+ drinks/occasion 0.80 0.26 2.44
1–12 days/year, <5 drinks/occasion 1.04 0.38 2.84
1–12 days/year, 5+ drinks/occasion 0.87 0.24 3.12
∗Analysis controlled for the same potential confounders as those listed in Table A1, including gender, age at Wave IV, race, BMI (calculated from measured
weight and height) at Wave III, parental self-reported diabetic status, frequency of parental alcohol use (from Wave I), smoking status at Waves I and III,
urbanity, and median income of residential location at Wave I.
∧
𝑃 value < 0.05.
Confounders are not shown; results were similar to those given in Table A1.
When current abstainers were chosen as the reference
group (no alcohol in the past 12 months), no significant
inverse association (i.e., protective effect) was found for
alcohol use and risk of diabetes. Instead, adolescents (i) who
drank more than three days per week and 5+ drinks per
occasion on average (OR = 12.57) and (ii) those who drank
alcohol 1–12 days per year and less than 5 drinks per occasion
(OR=2.46) had significantly higher risks of diabetes in young
adulthood. At Wave III, when participants aged a little over
22 years on average, there was no indication of any significant
association between alcohol consumption and risk of diabetes
(Table 2).
The association between alcohol use of index participants
and proxy outcome (parental self-reported diabetic status)
was only significant for current abstainers comparing to
lifetime abstainers atWave III, while no residual confounding
effect was detected for other categories (Table A2). When the
residual confounding effect (natural logarithm of 2.56) was
offset for current abstainers at Wave III, the odds ratio (95%
confidence interval) became 0.25 (0.09, 0.66). This estimate
is similar to the odds ratio of current abstainers at Wave I
(Table A1).
4. Discussion
To the best of our knowledge, this is the first study to
have specifically investigated the effect of alcohol use in
adolescence on the risk of diabetes in young adulthood (i.e.,
under 30 yrs). Frequent heavy alcohol use at an early age (i.e.,
under the age of 16 yrs and consuming an average of 5+ drinks
on 3 or more days/week) was associated with significantly
increased risk of diabetes: OR= 4.24, incidence rate increased
to 38.01 per 1,000 person-years when compared to lifetime
abstainers (incidence rate = 11.69 per 1,000 person-years), and
OR = 12.57 when compared to current abstainers (incidence
rate = 6.49 per 1,000 person-years). It is well established that
excessive alcohol use can lead to various forms of liver disease
[17, 18] as well as chronic or acute pancreatitis [19, 20]. Both
the liver and the pancreas play major roles in controlling
plasma glucose levels [21]. It is plausible that the strong
association between frequent risky drinking and the onset of
diabetes observed in this study is at least partly mediated by
liver and pancreatic injuries induced by alcohol at a time of
rapid physiological growth and development.
It was observed that, for all frequency categories, con-
suming less than 5 drinks per occasion at Wave I was not
significantly associated with reduced risk of diabetes. It was
also observed that adolescents who consumed alcohol 2–8
days permonth and 5+ drinks per occasion were significantly
associated with lower risk of diabetes compared to those
who had never consumed alcohol in their lifetime, but there
was no significant difference when compared to those who
had not consumed alcohol in the past 12 months (i.e., non-
lifetime, current abstainers). Furthermore, it was observed
that current abstainers at Wave I have lower risk of diabetes
comparing to lifetime abstainers. It is impossible to rule out
the possibility that infrequent high level alcohol use may
produce biological protective effect against diabetes in ado-
lescents; however, these findings indicated that the observed
protective effect for infrequent alcohol consumption at high
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level (5+ drinks per occasion) ismore likely to bemediated by
genetic and social factors that strongly associate with alcohol
use and health [10].
The likely presence of residual confounding effects was
also indicated by significant associations between parental
alcohol consumption and risk of diabetes among the par-
ticipants, which cannot be explained by the physiological
effects of alcohol. Adolescents who were able to tolerate
more than 5+ drinks per occasion while maintaining an
infrequent consumption pattern may be genetically different
from lifetime abstainers. It has been suspected formany years
that genetic predispositionmay be involved in the association
between moderate alcohol consumption and risk of diabetes
demonstrated by observational studies [22]. For instance,
variations in genes encoding alcohol dehydrogenase (ADH)
and aldehyde dehydrogenase (ALDH) (enzymes which are
responsible for ethanol metabolism) have been found to
play an important role in determining drinking patterns
[23]. After absorption, ethanol is oxidized to acetaldehyde
by ADH and acetaldehyde is then converted into acetate
by ALDH, and, therefore, for a given amount of alcohol
intake, the concentration of acetaldehyde in different people
is largely determined by the variants of ADH andALDH [24–
26]. Acetaldehyde is responsible for many of the unpleasant
side effects of alcohol use such as flushing, nausea, and
dizziness, which in turn can deter people from drinking
[24, 25, 27]. Recent research has provided some evidence
to suggest that ADH and ALDH variants may modify the
association between alcohol consumption and diabetes [28–
30] and coronary heart disease [31]. For example, Beu-
lens et al. showed that the “protective effects” of alcohol
consumption on diabetes were reduced among participants
carrying ADH alleles related to slower oxidation of ethanol
[28]. It is possible that inverse associations which appear
between adolescent risky drinking and the risk of diabetes
in adulthood are due to genetic predisposition, rather than
the protective effects of alcohol use itself. For instance, a
recent study by Ng Fat and Shelton showed that young adults
who had chronic illness were less likely to consume alcohol
[32]. The findings of the current study also concur with
recently published analyses of the National Health Interview
Surveys (USA) showing inverse associations between light
and moderate alcohol consumption of key participants and
the prevalence of adverse health status among their family
members, including children, which is indicative of residual
confounding [33].
There are some limitations to the current study. We were
unable to distinguish between type 1 and type 2 diabetes.
About 30% of participants were excluded from the analysis
due to missing information on one or more variables. Level
of physical activities and dietary intake was not controlled
in this study. This study was also subject to recall bias
(tendency toward underestimation) which is common to
almost all published cohort studies on alcohol and chronic
disease which rely on participant self-reported alcohol use.
To somewhat mitigate against this, we examined alcohol
consumption self-reported by the same participant in both
Waves I and III (i.e., repeated measures) and controlled for
consumption reported in both Waves I and III in analyses.
In addition, it should be noted that there were only a small
number of participants who frequently consumed alcohol
at 5 drinks or more in this study. There is no obvious
reason to suspect that the findings demonstrated here would
not be generalizable to similarly aged populations in the
developed nations with broadly similar drinking patterns
(e.g., Australia, UK, New Zealand, and Canada) or that the
significance of youth drinking will become less pressing in
the future. In Australia, for instance, there is evidence to
suggest that underage drinking at relatively heavy levels has
become increasingly common over the last few decades [12,
34, 35] despite its potential harms for physical and mental
development [36]. The findings from this study underscore
the importance of preventative approaches to alcohol misuse
among adolescents and children.
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